Company
Board Member
2023-03-07–present
Michael Torok
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Torok
The company reported in an 8-K filed October 30, 2024 that Michael Torok resigned as board of directors, effective October 31, 2024. The company reported in an 8-K filed March 8, 2023 that Michael Torok was appointed Board, effective March 7, 2023.
“On October 24, 2024, Michael Torok notified Carisma Therapeutics Inc. (the "Company") of his decision to resign from the Company's board of directors (the "Board"), effective October 31, 2024.”
“the Board and its committees were reconstituted, consisting of six directors designated by Carisma, who are Steven Kelly, Regina Hodits, Ph.D., Briggs Morrison, M.D., Björn Odlander, M.D., Ph.D., Chidozie Ugwumba and Sanford Zweifach, and one director designated by the Company, who is Michael Torok.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2023-03-07–present
-
Organization not stated
Board Member
SEC 8-K
2023-03-07–2024-10-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: board of directors
-
Executive change Appointed: Board